Skip to main content

Table 5 Risk for plaque and total plaque area at follow-up in persons with no plaque present at baseline, according to categories of fish consumption: the Tromsø Study

From: Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study

Fish servings (times/wk) N
1634
Novel plaque
N (%)
Risk for plaque
OR (95% CI)
TPAa
mm2 (SE)
Total fish
  < 1 116 44 (37.9) 0.98 (0.62–1.54) 1.52 (0.19)
 1–1.9 596 225 (37.8) 1 (Reference) 1.46 (0.08)
 2–2.9 416 181 (43.5) 1.15 (0.87–1.52) 1.62 (0.10)
  ≥ 3 506 250 (49.4) 1.32 (1.01–1.73) 1.76 (0.09)
p-trend    0.04 0.02
Fatty fish
  < 1 829 332 (40.1) 0.90 (0.72–1.13) 1.54 (0.07)
 1–1.9 631 280 (44.4) 1 (Reference) 1.63 (0.08)
  ≥ 2 174 88 (50.6) 1.18 (0.81–1.72) 1.75 (0.16)
p-trend    0.1 0.2
Lean fish
  < 1 142 55 (38.7) 0.99 (0.65–1.49) 1.57 (0.17)
 1–1.9 636 253 (39.8) 1 (Reference) 1.52 (0.08)
  ≥ 2 856 392 (45.8) 1.12 (0.89–1.41) 1.66 (0.07)
p –trend    0.4 0.3
  1. Models were adjusted for age, sex, systolic blood pressure, current smoking, total cholesterol, HDL-cholesterol, triglycerides, diabetes, leucocyte count, monocyte count, fibrinogen, CRP and anti-hypertensive medication
  2. TPA Total plaque area
  3. aSquare root transformed